Mellstedt H - Search Results

1

Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.

Hojjat-Farsangi M, Ghaemimanesh F, Daneshmanesh AH, Bayat AA, Mahmoudian J, Jeddi-Tehrani M, Rabbani H, Mellstedt H. Hojjat-Farsangi M, et al. Among authors: mellstedt h. PLoS One. 2013 Apr 8;8(4):e61167. doi: 10.1371/journal.pone.0061167. Print 2013. PLoS One. 2013. PMID: 23593420 Free PMC article. Retracted.

2

Characterization of the colorectal antigen IOR-C2.

Vazquez AM, Tormo B, Velandia A, Giscombe R, Ansotegui I, Jeddi-Tehrani M, Perez R, Mellstedt H, Biberfeld P. Vazquez AM, et al. Among authors: mellstedt h. Hybridoma. 1992 Apr;11(2):245-56. doi: 10.1089/hyb.1992.11.245. Hybridoma. 1992. PMID: 1376720

3

Monoclonal antibodies in cancer therapy.

Mellstedt H. Mellstedt H. Curr Opin Immunol. 1989-1990;2(5):708-13. doi: 10.1016/0952-7915(90)90035-f. Curr Opin Immunol. 1989. PMID: 2701972 Review. No abstract available.

4

Three kinds of tumour-unique surface molecules on a human T-cell chronic lymphocytic leukaemia (T-CLL) detected by monoclonal antibodies.

Janson CH, Jeddi Tehrani M, Mellstedt H, Wigzell H. Janson CH, et al. Among authors: mellstedt h. Scand J Immunol. 1987 Sep;26(3):237-46. doi: 10.1111/j.1365-3083.1987.tb02257.x. Scand J Immunol. 1987. PMID: 3498981

5

Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.

Halapi E, Yamamoto Y, Juhlin C, Jeddi-Tehrani M, Grunewald J, Andersson R, Hising C, Masucci G, Mellstedt H, Kiessling R. Halapi E, et al. Among authors: mellstedt h. Cancer Immunol Immunother. 1993;36(3):191-7. doi: 10.1007/BF01741091. Cancer Immunol Immunother. 1993. PMID: 8439980 Free PMC article.

6

CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.

Osorio LM, De Santiago A, Aguilar-Santelises M, Mellstedt H, Jondal M. Osorio LM, et al. Among authors: mellstedt h. Blood. 1997 Apr 15;89(8):2833-41. Blood. 1997. PMID: 9108402 Free article.

7

T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.

Halapi E, Werner A, Wahlström J, Osterborg A, Jeddi-Tehrani M, Yi Q, Janson CH, Wigzell H, Grunewald J, Mellstedt H. Halapi E, et al. Among authors: mellstedt h. Eur J Immunol. 1997 Sep;27(9):2245-52. doi: 10.1002/eji.1830270919. Eur J Immunol. 1997. PMID: 9341766

8

Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses.

Osterborg A, Yi Q, Henriksson L, Fagerberg J, Bergenbrant S, Jeddi-Tehrani M, Rudén U, Lefvert AK, Holm G, Mellstedt H. Osterborg A, et al. Among authors: mellstedt h. Blood. 1998 Apr 1;91(7):2459-66. Blood. 1998. PMID: 9516146 Free article. Clinical Trial.

9

T cell receptor usage in malignant diseases.

Halapi E, Jeddi-Tehrani M, Osterborg A, Mellstedt H. Halapi E, et al. Among authors: mellstedt h. Springer Semin Immunopathol. 1999;21(1):19-35. doi: 10.1007/BF00815176. Springer Semin Immunopathol. 1999. PMID: 10389230 Review. No abstract available.

10

Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset.

Rezvany MR, Jeddi-Tehrani M, Osterborg A, Kimby E, Wigzell H, Mellstedt H. Rezvany MR, et al. Among authors: mellstedt h. Blood. 1999 Aug 1;94(3):1063-9. Blood. 1999. PMID: 10419899 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page